arrow_back Back to App

Medicine Stockpile: Ensuring Generic Drug Availability in the US

This new law aims to create national stockpiles of essential generic drugs to prevent shortages. This ensures citizens will have access to necessary medications, even if supply chains are disrupted. The program is designed to secure at least a 6-month supply of these drugs.
Key points
Creating drug stockpiles: Reserves of up to 50 key generic drugs at risk of shortage will be established.
6-month availability: The stockpile aims to cover at least six months of demand, ensuring continuous access to medication.
Stockpile management: Companies will manage inventory to ensure drugs remain unexpired by regularly selling and replacing them.
Oversight and reporting: The government will monitor inventory levels and program effectiveness, with regular reports to Congress.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_405
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
Process start date: 2023-01-20
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Essential Medicines Strategic Stockpile Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_405.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-01-20.

What are the main provisions?

Key points include:

  • Creating drug stockpiles: Reserves of up to 50 key generic drugs at risk of shortage will be established.
  • 6-month availability: The stockpile aims to cover at least six months of demand, ensuring continuous access to medication.
  • Stockpile management: Companies will manage inventory to ensure drugs remain unexpired by regularly selling and replacing them.
  • Oversight and reporting: The government will monitor inventory levels and program effectiveness, with regular reports to Congress.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Carter, Earl L. "Buddy" [R-GA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health